首页> 外国专利> A METHOD FOR THE TREATMENT, PREVENTION, OR INHIBITION OF A CNS DISORDER AND/OR PAIN AND INFLAMMATION USING A COMBINATION OF DULOXETINE, VENLAFAXINE OR ATOMOXETINE AND A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND COMPOSITIONS THEREOF

A METHOD FOR THE TREATMENT, PREVENTION, OR INHIBITION OF A CNS DISORDER AND/OR PAIN AND INFLAMMATION USING A COMBINATION OF DULOXETINE, VENLAFAXINE OR ATOMOXETINE AND A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND COMPOSITIONS THEREOF

机译:结合度洛西汀,文拉法辛或阿托莫西​​汀和环氧化酶-2选择性抑制剂的治疗,预防或抑制中枢神经系统疾病和/或疼痛和发炎的方法及其成分

摘要

A method of treating, preventing, or inhibiting a CNS disorder and/or pain and inflammation or an inflammation-associated disorder in a subject in need of such treatment or prevention provides for treating the subject with duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor or prodrug thereof, wherein the amount of duloxetine, venlafaxine or atomoxetine and the amount of a cyclooxygenase-2 selective inhibitor or prodrug thereof together constitute a CNS disorder, pain and inflammation, or inflammation-associated disorder suppressing treatment, prevention, or inhibition effective amount of the composition. Compositions and pharmaceutical compositions that contain duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor are also disclosed.
机译:在需要这种治疗或预​​防的受试者中治疗,预防或抑制CNS病症和/或疼痛和炎症或与炎症相关的病症的方法提供了用度洛西汀,文拉法辛或阿托莫西​​汀和环氧合酶-2治疗该受试者。选择性抑制剂或其前药,其中度洛西汀,文拉法辛或托莫西汀的量和环氧合酶-2选择性抑制剂或其前药的量共同构成中枢神经系统疾病,疼痛和炎症或与炎症相关的疾病抑制治疗,预防或抑制有效量的组合物。还公开了含有度洛西汀,文拉法辛或托莫西汀和环氧合酶-2选择性抑制剂的组合物和药物组合物。

著录项

  • 公开/公告号WO2004060366A1

    专利类型

  • 公开/公告日2004-07-22

    原文格式PDF

  • 申请/专利权人 PHARMACIA CORPORATION;ARNERIC STEPHEN P.;

    申请/专利号WO2003US38751

  • 发明设计人 ARNERIC STEPHEN P.;

    申请日2003-12-06

  • 分类号A61K31/38;A61K31/415;

  • 国家 WO

  • 入库时间 2022-08-21 22:55:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号